Position in ALKS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,205
+$746 QoQ
Shares Held
23
+76.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#392
of 421 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bay Harbor Wealth Management, LLC holds $63,968 across 13 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,000 | $33,880 | |
| 2 | HLN |
Haleon plc
|
1,000 | $9,330 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
11 | $5,960 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
31 | $5,224 | |
| 5 | VTRS |
Viatris Inc
|
228 | $3,620 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
91 | $2,239 | |
| 7 | ALKS |
Alkermes plc.
This page
|
23 | $1,205 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
9 | $998 |
All Filings in ALKS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,205 | 23 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $459 | 13 | Shares | Other | 2026-04-14 | |
| 2025-12-31 | $279 | 10 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $330 | 11 | Shares | Other | 2025-10-09 | |
| 2025-06-30 | $114 | 4 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $66 | 2 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||